Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Cerilliant
Queensland Health
Express Scripts
Julphar
Moodys
Chinese Patent Office
Harvard Business School
Mallinckrodt
Federal Trade Commission

Generated: August 18, 2017

DrugPatentWatch Database Preview

INDOCIN Drug Profile

« Back to Dashboard

What is the patent landscape for Indocin, and when can generic versions of Indocin launch?

Indocin is a drug marketed by Iroko Pharms, Iroko Pharms Llc, and Recordati Rare. and is included in five NDAs.

The generic ingredient in INDOCIN is indomethacin sodium. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the indomethacin sodium profile page.

Summary for Tradename: INDOCIN

Patents:0
Applicants:3
NDAs:5
Suppliers / Packagers: see list1
Bulk Api Vendors: see list90
Clinical Trials: see list7
Patent Applications: see list4
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:INDOCIN at DailyMed

Pharmacology for Tradename: INDOCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Iroko Pharms
INDOCIN
indomethacin
SUPPOSITORY;RECTAL017814-001Aug 13, 1984DISCNYesNo► Subscribe► Subscribe► Subscribe
Iroko Pharms Llc
INDOCIN
indomethacin
CAPSULE;ORAL016059-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Iroko Pharms
INDOCIN
indomethacin
SUSPENSION;ORAL018332-001Oct 10, 1985RXYesYes► Subscribe► Subscribe► Subscribe
Iroko Pharms Llc
INDOCIN
indomethacin
CAPSULE;ORAL016059-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Iroko Pharms
INDOCIN SR
indomethacin
CAPSULE, EXTENDED RELEASE;ORAL018185-001Feb 23, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: INDOCIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Iroko Pharms
INDOCIN
indomethacin
SUPPOSITORY;RECTAL017814-001Aug 13, 1984► Subscribe► Subscribe
Iroko Pharms
INDOCIN
indomethacin
SUPPOSITORY;RECTAL017814-001Aug 13, 1984► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Covington
Express Scripts
Medtronic
Cerilliant
Dow
Moodys
Cipla
Baxter
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot